Ernexa Therapeutics (ERNA) Other Non Operating Income (2017 - 2025)
Historic Other Non Operating Income for Ernexa Therapeutics (ERNA) over the last 9 years, with Q3 2025 value amounting to $734000.0.
- Ernexa Therapeutics' Other Non Operating Income rose 10327.09% to $734000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $476000.0, marking a year-over-year increase of 10209.01%. This contributed to the annual value of -$22.4 million for FY2024, which is 661856.29% down from last year.
- Latest data reveals that Ernexa Therapeutics reported Other Non Operating Income of $734000.0 as of Q3 2025, which was up 10327.09% from -$123000.0 recorded in Q2 2025.
- In the past 5 years, Ernexa Therapeutics' Other Non Operating Income registered a high of $734000.0 during Q3 2025, and its lowest value of -$22.4 million during Q3 2024.
- Over the past 5 years, Ernexa Therapeutics' median Other Non Operating Income value was -$53000.0 (recorded in 2023), while the average stood at -$1.9 million.
- Its Other Non Operating Income has fluctuated over the past 5 years, first surged by 45365.85% in 2021, then plummeted by 224390000.0% in 2024.
- Ernexa Therapeutics' Other Non Operating Income (Quarter) stood at $290000.0 in 2021, then plummeted by 584.83% to -$1.4 million in 2022, then soared by 96.23% to -$53000.0 in 2023, then plummeted by 42239.62% to -$22.4 million in 2024, then surged by 103.27% to $734000.0 in 2025.
- Its last three reported values are $734000.0 in Q3 2025, -$123000.0 for Q2 2025, and -$135000.0 during Q1 2025.